Parvathi A Myer, MD
Gastroenterology · New Rochelle
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Montefiore Medical Center · 2,809 clinicians in this group
Hospitals listed: Montefiore Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Myer’s office at (866) 633-8255 to ask if they take your plan before you enroll.
California Medical Board record
Licence A101001 · Cancelled
Licence status: Cancelled · since 2007 · University of California, San Diego School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Montefiore Medical CenterBronx, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montefiore Medical Center, which runs 8 hospitalsHome of Montefiore Einstein Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 2 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.23 (1.01 to 1.45), Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.96 (4.4 to 7.52) · 3,522 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 0.95 (0.64 to 1.26) · 17,685 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.679, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.584, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.283, Oct 2024 – Sep 2025
See every measure and the patient survey for Montefiore Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 1 better, 7 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.23 (1.01 to 1.45) | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.96 (4.4 to 7.52) · 3,522 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.64 to 1.26) · 17,685 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.679 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.584 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.283 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.7 (0 to 1.48) · 3,839 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 173.71 (144.1 to 203.32) · 293 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 235 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 5.2 · 726 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.2 · 878 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 7.5 · 1,164 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.4 · 13,803 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.1 (0 to 0.26) · 18,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.05 to 0.36) · 20,155 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.42 (0.03 to 2.82) · 1,159 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.47 (1.29 to 3.65) · 3,435 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.77 (5.48 to 16.06) · 1,120 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.47 (3.29 to 9.65) · 1,192 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.57 to 3.28) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.8 · 1,424 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.812 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.336 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.058 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 17.8 · 722 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 2,620 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22 · 255 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18 · 840 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -6.4 · 886 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 2,180 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.1 (2.8 to 5.7) · 356 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.2 (10.5 to 16.3) · 356 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 1,427 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.9 · 170 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 22.3 · 973 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.3 to 16.2) · 803 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 627 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,904 patients answered, 11% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$14,416
Medicare paid this office $14,416 for 81 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $2,963 | $228 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $2,186 | $109 |
| Short return visit (20+ min) | 11 | $637 | $58 |
Procedures Medicare counted
| Colonoscopy | 39 | More than 59% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 19 | More than 50% of doctors who do this |
Who their Medicare patients are
81 Original Medicare patients in 2024. Average age 72 · Women 54% · Also on Medicaid 63% · Health risk score 2.58. Sicker patients than 9 in 10 peers; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 64% · Chronic kidney disease 53% · Coronary heart disease 49% · Heart failure 35% · COPD 27% · Depression 27% · Dementia 27% · Atrial fibrillation 22% · Stroke 21% · Cancer 15%.
The office billed $206,349, Medicare allowed $18,055 and paid $14,416; for 123 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 81 | 123 | 72 | 2.58 | $206,349 | $14,416 |
| 2023 | 102 | 145 | 74 | 3.28 | $200,232 | $15,833 |
| 2022 | 90 | 121 | 73 | 2.63 | $155,062 | $13,569 |
| 2021 | 112 | 168 | 71 | 3.12 | $224,546 | $20,459 |
| 2020 | 60 | 98 | 71 | 3.83 | $100,236 | $9,479 |
| 2019 | 88 | 122 | 71 | 3.34 | $120,629 | $13,610 |
| 2018 | 79 | 119 | 71 | 3.59 | $88,618 | $11,130 |
| 2017 | 69 | 99 | 74 | 2.38 | $107,246 | $8,981 |
| 2016 | 80 | 132 | 71 | 3.19 | $133,401 | $13,571 |
| 2015 | 27 | 93 | 66 | 3.40 | $36,389 | $8,785 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,799 | $122 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,762 | $110 |
| Return visit (30+ min) | 13 | $1,537 | $90 |
| Biopsy of large bowel using a flexible endoscope | 12 | $1,284 | $107 |
| Short return visit (20+ min) | 12 | $614 | $51 |
2022: 5 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,193 | $129 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,696 | $154 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,168 | $83 |
| Return visit (30+ min) | 12 | $1,157 | $89 |
| Short return visit (20+ min) | 13 | $777 | $56 |
2021: 4 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,739 | $129 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,792 | $127 |
| Biopsy of large bowel using a flexible endoscope | 14 | $1,582 | $113 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,523 | $117 |
2019: 4 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,555 | $232 |
| Biopsy of large bowel using a flexible endoscope | 17 | $1,657 | $97 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,354 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $726 | $66 |
2018: 3 services
| Biopsy of large bowel using a flexible endoscope | 12 | $1,798 | $138 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,320 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,104 | $65 |
2017: 2 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,196 | $92 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $492 | $35 |
2016: 2 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,500 | $125 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,311 | $94 |
Medicaid work
$1,088 in 2023
Medicaid paid $1,088 for 12 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $1,088 |
| 2023 | 12 | 1 | 12 | $1,088 |
Drugs they prescribed that Part D paid
$384,063
Pharmacies billed $384,063 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 231) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
165 generic and 66 brand-name prescriptions · $384,063 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Stelara | 11 | $291,814 | $26,529 |
| Linzess | 20 | $16,870 | $844 |
| Gavilyte-G | 46 | $630 | $14 |
| Famotidine | 36 | $418 | $12 |
| Sucralfate | 12 | $279 | $23 |
See all 7 drugs
| Stelara | 11 | $291,814 | $26,529 |
| Linzess | 20 | $16,870 | $844 |
| Gavilyte-G | 46 | $630 | $14 |
| Famotidine | 36 | $418 | $12 |
| Sucralfate | 12 | $279 | $23 |
| Omeprazole | 34 | $242 | $7 |
| Peg-3350 and Electrolytes | 15 | $203 | $14 |
Year by year
| 2024 | 231 | 100 | 0% (0) | 29% | $384,063 |
| 2023 | 301 | 118 | 0% (0) | 16% | $346,915 |
| 2022 | 275 | 95 | 0% (0) | 25% | $330,670 |
| 2021 | 214 | 61 | 0% (0) | 24% | $236,674 |
| 2020 | 166 | 65 | 0% (0) | 16% | $15,422 |
| 2019 | 269 | 87 | 0% (0) | 19% | $11,378 |
| 2018 | 281 | 87 | 0% (0) | 4% | $10,506 |
| 2017 | 213 | 52 | 0% (0) | 6% | $5,366 |
| 2016 | 360 | 100 | 0% (0) | 11% | $9,161 |
| 2015 | 56 | 30 | None | 21% | $1,846 |
| 2014 | 178 | 68 | 0% (0) | 11% | $23,360 |
| 2013 | 221 | 97 | None | 11% | $26,204 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Stelara | 12 | $309,491 | $25,791 |
| Linzess | 14 | $18,120 | $1,294 |
| Gavilyte-G | 76 | $1,199 | $16 |
| Dicyclomine | 19 | $1,195 | $63 |
| Famotidine | 70 | $1,173 | $17 |
| Omeprazole | 37 | $636 | $17 |
2022: 8 drugs
| Stelara | 12 | $297,588 | $24,799 |
| Linzess | 19 | $17,805 | $937 |
| Famotidine | 83 | $808 | $10 |
| Dicyclomine | 14 | $736 | $53 |
| Gavilyte-G | 39 | $584 | $15 |
| Loperamide | 12 | $514 | $43 |
| Peg-3350 and Electrolytes | 26 | $401 | $15 |
| Omeprazole | 27 | $188 | $7 |
2021: 4 drugs
| Linzess | 16 | $12,729 | $796 |
| Famotidine | 88 | $1,131 | $13 |
| Omeprazole | 17 | $352 | $21 |
| Peg-3350 and Electrolytes | 14 | $208 | $15 |
2020: 4 drugs
| Famotidine | 75 | $588 | $8 |
| Gavilyte-G | 28 | $344 | $12 |
| Peg-3350 and Electrolytes | 14 | $172 | $12 |
| Omeprazole | 12 | $67 | $6 |
2019: 8 drugs
| Linzess | 11 | $4,981 | $453 |
| Polyethylene Glycol 3350 | 19 | $1,646 | $87 |
| Sucralfate | 14 | $662 | $47 |
| Gavilyte-G | 45 | $654 | $15 |
| Ranitidine | 65 | $464 | $7 |
| Omeprazole | 47 | $289 | $6 |
| Peg-3350 and Electrolytes | 14 | $203 | $14 |
| Famotidine | 20 | $193 | $10 |
2018: 4 drugs
| Polyethylene Glycol 3350 | 97 | $7,850 | $81 |
| Gavilyte-G | 62 | $786 | $13 |
| Ranitidine | 58 | $365 | $6 |
| Omeprazole | 28 | $168 | $6 |
2017: 4 drugs
| Polyethylene Glycol 3350 | 80 | $3,578 | $45 |
| Gavilyte-G | 27 | $356 | $13 |
| Ranitidine | 54 | $269 | $5 |
| Omeprazole | 24 | $153 | $6 |
2016: 6 drugs
| Polyethylene Glycol 3350 | 122 | $4,155 | $34 |
| Gavilyte-G | 67 | $1,009 | $15 |
| Omeprazole | 49 | $296 | $6 |
| Peg 3350-Electrolyte | 15 | $206 | $14 |
| Peg-3350 and Electrolytes | 12 | $156 | $13 |
| Famotidine | 11 | $51 | $5 |
2014: 4 drugs
| Omeprazole | 61 | $1,584 | $26 |
| Pantoprazole | 24 | $635 | $26 |
| Ondansetron Odt | 11 | $407 | $37 |
| Gavilyte-C | 22 | $386 | $18 |
2013: 5 drugs
| Omeprazole | 84 | $2,248 | $27 |
| Gavilyte-C | 39 | $699 | $18 |
| Ondansetron Odt | 15 | $578 | $39 |
| Pantoprazole | 16 | $368 | $23 |
| Famotidine | 11 | $87 | $8 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1508006370
- Licence
- CA A101001California A101001: Cancelled
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr # S101, Stanford, CA, 94305
- NPI first listed
- 2009-03-05
- NPI last updated
- 2009-03-05
This is when the NPI record was last certified, not a medical board exam.